Comparative efficacy of biological treatments for moderate‐to‐severe psoriasis: a network meta‐analysis adjusting for cross‐trial differences in reference arm response

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|2|504-512

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.2, 2015-02, pp. : 504-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 454-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate‐to‐severe psoriasis

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 2, 2015-04 ,pp. : 131-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review and meta‐analysis of ustekinumab for moderate to severe psoriasis: comment

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 7, 2015-10 ,pp. : 810-811

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review and meta‐analysis of ustekinumab for moderate to severe psoriasis: comment

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 307-6938, Iss. 7, 2015-10 ,pp. : 810-811

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, efficacy, and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e163-e163

John Wiley & Sons Inc

Access to resources Recommend Favorite